Clinical Trial Update: Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents [Phase 4]

View source ↗

Summary

Phase 4 immunogenicity study evaluating Adacel and BOOSTRIX vaccines in adolescents has completed with results posted. The sponsor for this study is Sanofi Past…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• ADACEL (Tdap vaccine (tetanus, diphtheria and acellular pertussis vaccine))
• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Tetanus, Diphtheria | Phase 4 | Status: COMPLETED | Results posted: 2013-10-21